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Abstract
Cationic antimicrobial peptides, such as polymyxin and cecropin, activated transcription of osmY and micF in growing
Escherichia coli independently of each other. The micF response required the presence of a functional rob gene. It is intriguing
that in this and other assays an identical response profile was also seen with hyperosmotic salt or sucrose gradient, two of the
most commonly used traditional food preservatives. The osmY and micF transcription was not induced by hypoosmotic
gradient, ionophoric peptides, uncouplers, or with other classes of membrane perturbing agents. The antibacterial peptides
did not promote transcription of genes that respond to macromolecular or oxidative damage, fatty acid biosynthesis, heat
shock, or depletion of proton or ion gradients. These and other results show that the antibacterial cationic peptides induce
stasis in the early growth phase, and the transcriptional efficacy of antibacterial peptides correlates with their minimum
inhibitory concentration, and also with their ability to mediate direct exchange of phospholipids between vesicles. The
significance of these results is developed as the hypothesis that the cationic peptide antimicrobials stress growth of Gram-
negative organisms by making contacts between the two phospholipid interfaces in the periplasmic space and prevent the
hyperosmotic wrinkling of the cytoplasmic membrane. Broader significance of these results, and of the hypothesis that the
peptide mediated contacts between the periplasmic phospholipid interfaces are the primary triggers, is discussed in relation to
antibacterial resistance. ß 2000 Elsevier Science B.V. All rights reserved.
Keywords: Antibacterial peptides; Antibiotic resistance; Bacterial stasis ; Plasmolysis; Osmotic stress
0005-2736 / 00 / $ ^ see front matter ß 2000 Elsevier Science B.V. All rights reserved.
PII: S 0 0 0 5 - 2 7 3 6 ( 9 9 ) 0 0 1 7 7 - 7
Abbreviations: CCCP, carbonylcyanide m-chlorophenylhydrazone; EMS, ethyl methanesulfonate; FC1%, the £uorescence increase
induced by 1 mol% peptide in the PyPG exchange assay; LPS, lipopolysaccharide; MIC, minimum growth inhibitory concentration in
60 min; NP, polymyxin B (2^10)-nonapeptide; OM, outer membrane Gram-negative organism; POPG, 1-palmitoyl-2-oleoylglycero-sn-3-
phosphoglycerol; PxB, polymyxin B; PyPG, 1-palmitoyl-2-pyrenedecanoyl-phosphatidylglycerol ; TLRC, threshold luminescence response
concentration
* Corresponding author. Fax: +1-302-831-6335; E-mail : mkjain@udel.edu
1 Also a⁄liated with Department of Chemical Engineering, University of Delaware.
2 Present address: Laboratory for Environmental Microbiology, The Hebrew University of Jerusalem, Israel.
BBAMEM 77723 27-12-99
Biochimica et Biophysica Acta 1463 (2000) 43^54
www.elsevier.com/locate/bba
1. Introduction
Ubiquitous antimicrobial peptides [1^5] are a part
of the innate immune system [6] of virtually all or-
ganisms. Some of the better characterized examples
include polymyxins of Gram-positive Polymyxa spp.
[7], magainins of frog skin [6,8^10], cecropins of in-
sect larvae [11,12], thionins of plants [13], and defen-
sins from humans and other animals [2,14]. Evolu-
tionary success of antimicrobial strategies with target
selectivity suggests solution to the problem of anti-
biotic resistance that could provide insights into the
management of infection.
It is generally believed that the bacterial membrane
is the primary target of antimicrobial cationic pep-
tides [2,7]. The fact that these antimicrobials do not
cause signi¢cant damage to organisms that produce
them, suggests speci¢c mechanisms of action, rather
than a lytic mechanism that causes leakage of cyto-
plasmic content. We have developed strategies and
protocols to determine the metabolic stress induced
in growing Escherichia coli by antimicrobials [15,16].
The conceptual basis for this assay lies in the fact
that viable organisms often respond and adapt to
sub-lethal environmental adversities by increased ex-
pression of stress proteins to restore homeostasis
[17,18]. The transcription of a speci¢c stress pro-
moter is obligatorily coupled to a bacterial lumines-
cence reporter luxCDABE operon on a plasmid in-
troduced in E. coli. Such fusion strains (Table 1)
produce luminescence at sub-lethal level of the stress
[19^27]). Speci¢c stress response is measured with
cells in the growth phase treated with concentrations
of the antimicrobial agent below its growth inhibi-
tory concentrations. Under these conditions the
growth-dependent metabolic processes are stressed
but are not turned o¡, therefore cells respond and
achieve homeostasis. By design, this method provides
a measure of the physiological change that requires
onset of transcription with the response time of sev-
eral minutes at the sub-lethal doses. Extension of the
stress^response results to establish the antimicrobial
basis derives from the assumption that continued
excessive stress leads to bacteriostasis, and ultimately
to cell death.
In this paper we characterize the nature of the
stress induced by several cationic peptides on
E. coli. The promoter-coupled luminescence techni-
que showed that the stress induced by cationic pep-
tides like PxB selectively enhanced the expression of
micF encoding an antisense RNA that inhibits ex-
pression of the OmpF porin, and osmY encoding
an osmotically-induced periplasmic protein. Expres-
sion initiated at these two promoters was also in-
duced by hyperosmolar NaCl or sucrose, two of
the most commonly used food preservatives.
Although transcription of micF and osmY is in£u-
enced by similar factors, the e¡ect is independent
of each other. The signi¢cance of the primary inter-
action with phospholipid targets is discussed in rela-
tion to antibiotic resistance.
2. Materials and methods
2.1. Reagents and growth media
PxB, bacitracin, gramicidin A, gentamicin, valino-
mycin, and agarose were from Sigma. Magainins,
cecropins and mastoparans were from Bachem. Col-
istin was from Waku Chemical Co. PxB-agarose and
NP were from Boehringer. CCCP was provided by
Dr. P. Heytler (DuPont Co.). The purity of the pep-
tides was con¢rmed by analytical HPLC. Sources of
phospholipid and protocols to monitor phospholipid
exchange is described in detail elsewhere [40,41].
The M9 medium contained (per liter) 6 g Na2HPO4,
3 g KH2PO4, 0.5 g NaCl, 1 g NH4Cl; after autoclav-
ing 1 ml of 1 M MgSO4, 0.1 ml of 1 M CaCl2,
10 ml of 20% glucose, and 1 mg thiamine were
added. LB medium (Sigma) was used as described
[15,16].
2.2. Fusion strains, growth conditions and
luminescence response
The panel of stress responsive lux fusion strains
used in this study is listed in Table 1. Plasmid pMic-
FLux1 containing a fusion of the micF promoter
region to the Vibrio ¢scheri luxCDABE operon in
the parental plasmid pUCD615 [28] was made by
PCR ampli¢cation according to a previously de-
scribed method [24] using the primers: 5P-ACTT-
AAGGATCCCCCCAAAAATGCAGAATA-3P and
5P-AGCAGCGAATTCGGGCATCCGGTTGAAA-
TAG-3P. The ampli¢ed product contains 244 base
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pairs upstream of the start site of the micF RNA and
the entire transcribed region.
A series of E. coli strains that are isogenic with the
exception of chromosomal mutations in the genes
encoding certain regulatory proteins were used to
test their e¡ects on micF expression. E. coli strains
DPD2191, DPD2192, DPD2193 and DPD2194 were
made by transformation using plasmid pMicF-Lux1
into E. coli strains GC4468 (F-vlac4169 rpsL) [30],
N7840 (F-vlac4169 rpsL v(mar sad)1738) [31],
BW829 (F-vlac4169 rpsL vsox-8: :cat) [32], and
RA4468 (F-vlac4169 rpsL rob: :kan) [30], respec-
tively. Strain DPD2220 was constructed by transfor-
mation of pDEW221 with the osmYP-luxCDABE fu-
sion into strain RA4468 with the chromosomal rob3
mutation.
The transcriptional responses were assayed by pre-
viously established protocols [16]. Brie£y, turbidity
and luminescence measurements were carried out at
30‡C with shaking at 200 rpm in LB medium con-
taining 50 Wg/ml kanamycin monosulfate or ampicil-
lin to maintain the plasmid. The OD (Spectronix
2000, Bausch and Lomb) at 600 nm of the culture
(OD600) was measured after 5- to 15-fold dilution in
the medium at the indicated intervals. When OD600
reached 0.2, 5 ml culture broth was transferred to a
25 ml £ask, followed by the addition of appropriate
concentration of a pre¢ltered (0.2 Wm ¢lter) inducer
(Table 2), or peptide, or suitable controls. Controls
with NP were based on the observation that NP
interacts with the bacterial LPS layer but it is a
very weak antibacterial. Luminescence of the culture
broth was monitored without dilution by transferring
a 0.2 ml aliquot to 1.5 ml polyethylene tubes (Turner
Design) on a Model 20e Turner Design luminometer
pre-set at a constant sensitivity. For comparison pur-
poses the signal intensities in arbitrary units are ex-
pressed as L/LC31, where L is the observed lumines-
cence under a given set of conditions for the stress
variable, and LC is the control luminescence without
the stress. The error bars are not shown; however,
replicate assays were routinely carried out. Typically
the scatter was less than 10% in the absolute reading;
however, the luminescence changes signi¢cantly with
the growth conditions. Independent controls were
also carried out to show that the cells are viable after
the luminescence measurements.
Comparable growth and assay conditions were
used to monitor the e¡ect of washed PxB-agarose
[7] suspended in the autoclaved LB medium and
shaken for 30 min. Similarly, cultures of E. coli or
several Pseudomonas species in the early log phase
were transferred to fresh medium containing PxB at
its MIC, and then at successively higher concen-
trations. Analysis of the growth medium showed
that s 80% of the peptide was still intact and active.
Fatty acid analysis to identify bacterial strains was
carried out as described [37]. Standard protocols
were used for UV and chemical (EMS) mutagenesis
[38].
2.3. E¡ects of antimicrobial peptides on the
biophysical properties and phospholipid exchange
Strategies, protocols and controls for the phospho-
lipid exchange and other biophysical e¡ects of PxB
[39^41] have been established. Such protocols distin-
guish the peptide-mediated leakage of the aqueous
content, (hemi-)fusion of vesicles, solubilization of
the bilayer, transbilayer movement, and the exchange
of phospholipid between the outer monolayers of
vesicles kept in contact through a peptide or protein.
Pyrene-labeled phospholipid dequenching assay was
used to quantify the peptide contact mediated phos-
pholipid exchange. Typically, the £uorescence in-
crease at 396 nm (excitation 346 nm) was monitored
as a function of time after the addition of a known
mole fraction of the peptide to a mixture of pyPG/
POPC (70:30) covesicles with a 125-fold excess of
unlabeled phospholipid covesicles of DMPG/POPC
(70:30). The total concentration of phospholipid
was 125 WM.
3. Results
3.1. Selectivity of the peptide-induced stress
Each of the E. coli strains A^L (Table 1) contains
a plasmid-borne genetic fusion of one of several pro-
moter regions of E. coli stress responsive genes to a
bioluminescent luxCDABE operon. Transcription in-
itiated at the promoter region sequentially drives ex-
pression of the lux genes resulting in a biolumines-
cence response that requires the presence of ATP
from the cytoplasm of viable cells. Therefore, in-
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creased transcription initiation, due to stress respon-
sive regulation of gene expression, leads to increased
transcription of the lux reporter and hence increased
bioluminescence.
The growth inhibitory e¡ect of sub-lethal con-
centration of PxB on the lac-lux E. coli strain E
(TV1048) and of osmY-lux strain G (DPD2170) are
compared in Fig. 1. The change in turbidity and
luminescence of the lac-lux E. coli strain E follow a
similar time-course during the early growth phase.
This is expected because the luminescence increase
is due to an increased cumulative expression of lac-
Table 2
Luminescence response from the stress sensitive strains A^K of E. coli to peptides and other additives
Peptide Strains A^F G H I J K L
1. PxB 3 + + + + 3 +
2. NP 3 ws ws ws ws 3 *
3. Colistin 3 + + + + 3 *
4. Colistin+NP 3 + + + + 3 *
5. Cecropin A 3 + + + + 3 *
6. Cecropin B 3 + + + + 3 *
7. Magainin 1 * + 3 * * * *
8. Magainin 1+NP * ws 3 * * * *
9. Magainin 2 * + 3 * * * *
10. Magainin 2+NP * ws 3 * * * *
11. Mastoparan X * ws 3 * * 3 *
12. Mastoparan X+NP * + + + + 3 *
13. Mastoparan 17+NP * 3 3 * * * *
14. Gramicidin A+NP 3 3 3 * * * *
16. Valinomycin+NP * 3 3 * * * *
17. Gentamicin+NP * 3 3 * * * *
18. Bacitracin+NP * 3 3 * * * *
19. CCCP 3(A,B,C,E,F)/+D 3 3 3 3 ws *
20. Polylysine * 3 3 * * * *
21. Protamine * 3 3 * * * *
22. NaCl 3 + + + + ws +
23. Sucrose 3 + ws ws ws ws ws
Strains A^L (Table 1). More than 2-times increase in the luminescence is indicated by +. Less than 2-times increase above the back-
ground is indicated as a weak signal (ws). No detectable luminescence increase is shown as (3). *, not characterized.
Table 1
Properties of the stress-sensitive strains of E. coli
Gene type (: :lux)/host Strain Stress Inducer (conc.) Ref.
A grpEP/* TV1061 Protein folding Ethanol (0.5 M) [23]
B recAP/* DPD2794 DNA damage Mitomycin C (0.3 mM) [29]
C katGP/* DPD2511 Oxidative H2O2 (15 mM) [20]
D inaAP/* DPD2146 Proton leakage Salicylate (1 mM) [27]
CCCP (15 WM)
E lac/* TV1048 Limited carbon source [16]
F fabA/* DPD1674 Fatty acid synthesis Cerulenin (0.02 mM) [33^35]
G osmYP/* DPD2170 Hyperosmotic Sucrose or NaCl (0.5 M) [27]
H micF/* DPD2191 Superoxide Methyl viologen TW
I micF/marÿ DPD2192 Superoxide Methyl viologen TW
J micF/soxÿ DPD2193 Superoxide Methyl viologen TW
K micF/robÿ DPD2194 Superoxide Methyl viologen TW
L osmY/robÿ DPD2220 Superoxide Methyl viologen TW
TW, this work as described in Section 2.
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lux genes with the increase in the cell population. In
contrast, the osmY-lux E. coli strain G displayed an
increased luminescence after 30 min of PxB treat-
ment indicating an induction gene expression initi-
ated at the osmY promoter. The TV1048 strain E is
also well suited to monitor the e¡ect of leakage and
energy depletion in the cell because the luminescence
reaction requires continuous supply of energy. In
such assays of the short-term (6 5 min) e¡ects, the
luminescence loss by CCCP above its MIC is pro-
nounced [15]. This reduction in luminescence is ex-
pected if the ATP level required for the luminescence
reaction is lowered due to a depletion of the proton
gradient. However, even at 10 times above their min-
imum growth inhibitory concentrations, none of the
peptides that we tested induced a rapid decrease
(data not shown). Thus, proton leakage and loss of
ATP is ruled out as the basis for the peptide induced
antimicrobial stress (see also [15] and [16]).
Fig. 1. E¡ect of PxB on the time-course of growth of: (A) lac-
lux containing TV1048 strain E, or (B) osmY-lux containing
DPD2170 E. coli strain G. The changes were monitored as tur-
bidity (squares, dotted line), or the luminescence increase
(circles, full line) in the absence (open symbols) or presence
(closed symbols) of 0.25 WM PxB. Note that the values of the
X- and Y-axes are di¡erent in A and B. Similar growth curves
in the presence of sublethal 10 WM CCCP showed no e¡ect in
both cases (results not included, however see Tables 2 and 3).
Fig. 2. The [PxB] (open circles) and [colistin] (triangles) depen-
dence of the luminescence (open symbols) or turbidity (closed
circles shown only for PxB) change after 60 min growth of (A)
osmY-lux DPD2170 strain G or (B) micF-lux (marsoxrob)
DPD2191 strain H. These results are parameterized (and sum-
marized in Table 2) as: TLRC, threshold luminescence response
concentration for the 60 min incubation; MIC, the minimum
growth inhibitory concentration at 60 min. Note that the Y-
scale is expressed in arbitrary units to emphasize the fact that
in such cases the background luminescence is low, and therefore
it is not meaningful to express the change as a ratio.
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3.2. The transcription response is speci¢c to osmY and
micF fusions
The luminescence response protocol outlined in
Fig. 1 was used to screen the e¡ects of several anti-
bacterial agents at MIC. As summarized in Table 2,
the luminescence responsiveness of the A^L fusion
strains to peptides and other forms of stresses shows
a remarkable speci¢city for the structure of the pep-
tide. Speci¢c protocols and controls for these results
are developed below. Antimicrobial peptides 1
through 12 and the hyperosmotic NaCl (#22) or su-
crose (#23) induce luminescence response in the
osmY-lux strain G. The micF-lux strain H exhibits
virtually the same response pro¢le, except that the
response with magainins (#7^11) was not signi¢cant.
Note that the stresses #1^6, 22 and 23 do not induce
transcriptional responses from strains (A^F) that re-
spond to macromolecular damage, depletion of the
proton gradient, or oxidative damage. Similarly, the
antibacterial stresses #14^21 do not show a response
with strains G and H. Also, the proton-leakage re-
sponsive strain D does not respond to other stresses.
The response pro¢les for the osmY-lux strain G
(Fig. 2A) and the micF-lux strain H (Fig. 2B) are
biphasic. The maximum luminescence response in
both strains is seen in the vicinity of the minimum
growth inhibitory concentrations of polymyxin and
colistin. Note that these plots are on linear ordinates,
rather than on a logarithmic scale that is often used.
With the use of a linear ordinate the concentration
dependence of the response is signi¢cantly expanded
in the region of the stress measured as the lumines-
cence response.
The luminescence response from micF-lux fusion
strain H to hyper- and hypoosmotic stress is shown
in Fig. 3. The increase in luminescence is seen with
hyperosmotic NaCl, but not with hypoosmotic stress.
A modest growth inhibition is seen with both hypo-
and hyperosmolar NaCl (data not shown). These re-
sults are similar to those induced by NaCl and su-
crose in osmY-lux strain G [15,16], and suggest that
the luminescence response of strain H from the in-
duction of micF is primarily due to an increase in the
osmolarity.
The expression of micF is controlled by three chro-
mosomal regulatory genes, marA, soxS and rob, the
products of which bind to the micF promoter region
[30,31,42^44]. As summarized in Table 2, deletion of
marA in strain I (DPD2192) or soxS in strain J
(DPD2193) did not alter the response pro¢les for
the peptides or the hyperosmotic shock. On the other
hand, inactivation of the rob gene in strain K led to
the complete loss of the peptide induced lumines-
cence and weakening of the hyperosmolarity induced
luminescence. In contrast, the osmY/robÿ strain L
was responsive to polymyxin demonstrating that
functional rob is not required for the osmY response.
These results clearly show that both micF and osmY
genes respond independently to the same set of
stresses induced by hyperosmosis and the antibacte-
rial peptides.
3.3. Antibacterial activity correlates with the ability of
peptides to form contacts between phospholipid
vesicles
Results in Table 3 show that polymyxin, colistin,
cecropins, and magainins are growth inhibitory and
induce the osmY transcriptional response. The MIC
and the threshold luminescence response concentra-
tion (TLRC) change with the structure of the pep-
tide. As compared in Fig. 4 (circles), MIC and TLRC
are not only correlated with each other but also with
the ability of the peptides to mediate phospholipid
exchange between vesicles through stable contacts
[38^40]. A direct and rapid exchange of monoanionic
phospholipid through peptide contacts is monitored
as a dequenching signal due to dilution of the probe
phospholipid pyPG. The vesicles in contact do not
Fig. 3. The change in the luminescence during the growth of
micF-lux DPD2191 strain H in the NaCl-free LB medium with
0 M (circles), 0.1 M (triangles), 0.3 M (squares) and 0.5 M (di-
amonds) NaCl.
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exchange with excess vesicles. Thus the magnitude of
the signal depends on the number of vesicles in con-
tact, which increases with the concentration of the
peptide. From the linear plot of the amplitude of
the dequenching signal versus the peptide mol%
(Fig. 5), we obtained the fractional change in the
signal at 1 mol% peptide in the interface. The recip-
rocal of the amplitude is de¢ned as FC1% values
summarized in Table 3. Since these values are ob-
tained from a linear plot, they are directly related
to the e¡ectiveness of peptides to form vesicle^vesicle
contacts.
Qualitatively, all antimicrobial peptides 1^12 pro-
mote exchange of PyPM, and a modest exchange is
seen even with PxB-agarose (data not shown). No
phospholipid exchange is seen with bacitracin, gen-
tamicin, gramicidin, valinomycin and mastoparan-17
(data not shown). As shown in Fig. 4 (#), FC1%
trends with TLRC, that is at least qualitatively, the
ability of PxB to form contacts correlates with
growth inhibition and the transcriptional lumines-
cence response. A possible origin of the scatter in
the correlation of TLRC or MIC with FC1% lies in
the fact that the action of the peptide on whole cells
involves at least two steps: disruption of the outer
lipopolysaccharide layer, and the interaction of the
peptide with the lipidic components surrounding the
periplasmic space. The FC1% values provide only a
measure of the contact formation between phospho-
lipid vesicles.
Several controls were also designed to identify the
primary locus of action of the cationic antibacterial
peptides on the basis of the hypothesis that the pep-
tides could form stable contacts between the phos-
pholipid interfaces of the bacterial periplasmic space.
Fig. 4. Correlation between TLRC and MIC (open circles) or
FC1% (#). From results in Table 3.
Fig. 5. The change in (F3Fo) in the monomer £uorescence
emission (at 398 nm with excitation at 345 nm) on the addition
of varying amounts of cecropin B (circles), gramicidin (closed
triangles), or PxB-nonapeptide (open triangles). Dequenching of
pyPG/POPC (7:3) vesicles (2 WM total lipid) occurs as the pyr-
ene probe is transferred through the peptide mediated contacts
formed with a 125-fold excess of DMPG/POPG (7:3) vesicles.
FC1% value (Table 3) is de¢ned as the reciprocal of the frac-
tional change in the £uorescence in the presence of 1 mol%
peptide added to the mixture of donor and acceptor vesicles.
Table 3
Concentrations (WM) for inhibition of growth (MIC) and for
threshold luminescence response (TLRC)a parameters for osmY-
lux strain G of E. coli
No. Peptide TLRC MIC FC1%
1 Polymyxin B (PxB) 0.1 0.2 0.9
2 PxB-nonapeptide (NP) 30 40 10.2
3 Colistin 0.1 0.15 1.9
4 Colistin+NP 0.07 0.15 ^
5 Cecropin A 0.07 0.1 0.3
6 Cecropin B 0.035 0.1 0.2
7 Magainin 1 5 12 7.8
8 Magainin 1+NP 5 10 ^
9 Magainin 2 3 5 9.1
10 Magainin 2+NP 5 15 ^
11 Mastoparan X 8 12 0.72
12 Mastoparan X+NP 3 4 1.5
aSee Fig. 3A for the de¢nition of parameters. TLRC, threshold
luminescence response concentration; FC1%, the reciprocal of
the signal (as % of the maximum change in the £uorescence, in-
duced by 1 mol% peptide in the PyPG exchange assay); all
measured parameters have an uncertainty of 20% on the same
culture. Based on the repeated runs the uncertainty in these pa-
rameters is 30%. 10 WM NP, if present as the second compo-
nent. N, no detectable e¡ect.
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For example the luminescence response from the
osmY strain G is induced by PxB-agarose (results
not shown), where the peptide is bound to agarose
bead. Since PxB-agarose also has antibacterial activ-
ity [7,47,48], we conclude that entry of PxB in the
cytoplasm is not required.
NP, the truncated (2^10)-PxB nonapeptide, inhib-
its growth at a 200-fold higher concentration (Fig. 6).
Origin of the response from NP is probably not due
to the presence of PxB as an impurity because the
peak luminescence intensity with PxB is considerably
larger. Also, HPLC analysis on a C18 reverse phase
column showed no detectable (6 0.05%) amount of
PxB as an impurity in the NP preparation. We
should have been able to detect such an impurity
because NP and PxB are well separated. NP binds
to LPS and disrupts the outer membrane of Gram-
negative organisms with virtually the same e⁄cacy as
PxB, and NP makes the cytoplasmic membrane ac-
cessible to other solutes that do not otherwise cross
the outer membrane [3,36,45,46]. Based on these re-
ports, we rule out disruption of the outer membrane
as a su⁄cient condition for the osmY or micF tran-
scription, although results described next suggest that
such a disruption of the outer layer is a necessary
condition for the antimicrobial e¡ect.
Ionophores like gramicidin A or valinomycin did
not inhibit growth of the osmY-lux strain G unless 10
WM NP is also added to the growth medium (data
not shown). This is because these peptide do not
cross the outer membrane [49] unless NP disrupts
the outer membrane and the peptide enters the peri-
plasmic space. Note that 10 WM NP shows virtually
no growth inhibition, nor any osmY response (Fig.
6). NP had little or no e¡ect on the osmY response
induced by peptides that induce the osmY response
alone, and the micF transcriptional response was not
seen with a growth inhibitory combination of NP
and ionophores (Table 2). For example, as shown
in Fig. 7, 2 WM gramicidin A or 5 WM NP alone
have no detectable e¡ect on the time course of the
background luminescence increase from growing
osmY-lux strain G. In comparable experiments we
did not see an increase in the luminescence at sub-
lethal concentrations of gramicidin in the presence of
NP. The fact that sub-lethal concentrations of gra-
micidin and NP showed no detectable increase in
luminescence, suggests that the gramicidin-induced
ion leakage through the cytoplasmic membrane
does not induce the osmY transcriptional response.
Virtually identical results are seen with valinomycin
(not shown).
3.4. Adaptation and Resistance to PxB
An expectation of the hypothesis that phospholip-
id is the primary molecular target of PxB is that it
may not readily succumb to some of the resistance
mechanisms, such as the point mutation. Our results
(not shown) a⁄rm this expectation at several levels.
Fig. 6. The [NP] (open circles) and [PxB] (squares) dependence
of the luminescence response after incubation for 60 min with
growing osmY-lux DPD2170 strain G. The change in OD600 as
a function of [NP] is shown as closed circles.
Fig. 7. The time dependence of the luminescence response with
growth of osmY-lux DPD2170 strain: control without an addi-
tive (open circles), with 2 WM gramicidin A (triangles), with
5 WM NP (squares), or with 2 WM gramicidin A and 5 WM NP
(closed circles). No luminescence increase was observed at the
sub-lethal gramicidin+NP.
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For example, as discussed later, certain PxB-resistant
strains have modi¢ed Lipid A moiety, which presum-
ably impairs PxB binding necessary for its uptake.
By HPLC and quantitative growth inhibition cri-
teria, PxB is resistant to degradation under a variety
of conditions (results not shown), although cecropin
is degraded [16]. Resistance of PxB to degradation in
the culture medium of several E. coli and Pseudomo-
nas species permitted adaptation studies. Growth in-
hibition of the alginate+ strain by PxB suggests that
the mucoid layer [50] does not prevent the action of
PxB. Long term exposure of TV1048 E. coli strain
and several P. aeruginosa (ATCC 10145 (type strain)
and 27853; FRD1 (aliginate+), FRD1003 (algi-
nate3)) or P. putida (ATCC33015) to PxB did not
yield any stable growth. In agreement with earlier
reports [51^53], only one strain of P. aeruginosa
(PA10145 ATCC), showed a slow adaptation on
PxB-gradient plates or by successive transfers to a
medium containing 2^4 times MIC of PxB. In this
strain cross-protection against 30 WM PxB was in-
duced within 3 h in PA10145 cultures exposed to
100 WM NP. However, transfer of the 0.5 mM PxB
adapted culture to a PxB-free medium restored the
original PxB sensitivity, monitored as MIC, in less
than 5 generation times. The metabolic pro¢le (mea-
sured with the kit from Biolog) and the fatty acid
composition of the original, adopted, and reverted
strains were indistinguishable.
As a mechanism for adaptation, a point mutation
in a protein receptor can render it ine¡ective against
a drug. We searched for PxB-resistant strains in the
EMS- or UV-mutagenized population of TV1048
and P. aeruginosa (ATCC 10145). Both of these
strains did not yield a resistant strain. Within the
limitation of the search, our negative results suggest
that PxB resistance is not readily induced. Since the
signi¢cance of these negative results is far-reaching, a
more detailed search is warranted.
4. Discussion
Hyperosmotic stress and exposure to cationic pep-
tide antibacterials selectively and independently pro-
motes micF and osmY expression. The molecular
functions of these gene products are not known;
however, the regulatory circuits that control their ex-
pression are outlined in Fig. 8. Three general tran-
scriptional regulatory factors that control several
genes are implicated in stresses that concern us
here. c70 controls the osmoregulated ProU and
ProP pumps, the proton-coupled transport proteins
of the cytoplasmic membrane that control the solute
e¥ux for the recovery from the hyperosmotic shrink-
age of the cytoplasm. Also as a guide for future stud-
ies note that, as suggested to us by Dr. Patrick Brown
(Stanford) on the basis of limited data, the expression
pattern of osmY is similar to that of osmC followed
by osmE and Ybay. Similarly, expression pattern of
rob is similar to Yfga, followed by Yabc, Yabb, Rlpb,
Ychk and Nagc. As discussed below, the micF expres-
sion controlled by rob, and the osmY expression con-
trolled by cS are independently related to the action
of antibacterial peptide or hyperosmotic stress.
4.1. Role of rob
Three di¡erent factors control micF transcription.
Fig. 8. Regulatory circuits in E. coli that respond to hyperos-
motic shock, PxB, starvation, superoxide exposure, or drug in-
£ux. The e¡ects of these stresses in the cytoplasm are regulated
by the transcriptional regulators: c70, cS, or rob. Transcription
of cS regulated osmY gene is promoted by starvation, hyperos-
motic stress, as well as by PxB and related cationic peptide
antibacterials. As suggested by results in the accompanying pa-
per [60], these responses may be related to an event associated
with the cytoplasmic membrane. Transcription of micF, which
controls transcription of ompF, is regulated by rob and pro-
moted by the same stresses. On the other hand, proU and proP
transcription, which control the recovery from osmotic shrink-
age, is regulated by c70.
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Expression of micF-lux fusion is induced by the re-
dox cycling agent methyl viologen under the control
of the soxRS regulatory circuit that respondes to the
superoxide stress [20]. As expected, transcription of
the soxSÿ strain J was not induced by methyl viol-
ogen. Expression of micF is also known to be in-
duced by binding of the multiple antibiotic stress
response regulator marA [42]. Over-expression of
rob, sox or marA confers resistance to pegnazine me-
thosulfate, as well as to antibiotics like chloram-
phenicol, tetracycline, nalidixic acid, or puromycin
[30]. MicF produces an anti-sense RNA that inhibits
expression of ompF encoding a porin. This circuit
accounts for the regulation of drug in£ux. A distinct
expression pattern for Rob versus SoxS and MarA is
also reported for certain genes (sodA, nfo, zwf, inaA,
fumC, sodA) [30].
Our results suggest that the detailed role of rob,
soxS and marA gene activators is di¡erent because
only rob is required for the response to the peptide or
hyperosmotic stresses. Therefore, a role for the Rob
protein is implicated in the response to the antimi-
crobial stress. Rob may also be involved in the micF
response to hyperosmotic stress because a weakened
response was observed in strain K lacking functional
rob. A signal transduction pathway for the Rob pro-
tein has not been previously described. Rob is a
DNA binding regulatory protein that binds to sev-
eral promoters [54]. These results further suggest that
the type of stress the cell sustains upon these treat-
ments is distinct from previously known stresses. It is
quite likely that in response to hyperosmolarity and
the antibacterial stress rob may regulate expression
of certain other proteins. However, the negative re-
sults in Table 2 clearly place certain constraints on
such regulatory connections.
4.2. Role of osmY
OsmY is a hyperosmotically inducible gene that
encodes a periplasmic protein in E. coli [55^58].
There are several stationary-phase responsive genes,
and their products have a wide range of functions
spread over several metabolic compartments. The
rpoS-encoded sigma factor cS has been identi¢ed as
a central regulator of many of these genes whose
expression are stimulated by starvation or the onset
of the stationary phase [55]. Transcription of osmY is
directly regulated by cS, as well as several other reg-
ulators [56^58]. Also, cS expression is osmotically
stimulated by a mechanism that operates at the levels
of translation and cS protein turnover [58,59]. The
transcription of osmY promoter occurs under all con-
ditions; however, it is stimulated by hyperosmolarity,
cell density, starvation, or other growth phase sig-
nals. Under these conditions, osmY expression is re-
duced but not eliminated in rpoS mutant [56]. Using
a mutant that produces temperature sensitive c70, it
has been shown that shifting this mutant strain to
nonpermissive temperature did not a¡ect osmotic ac-
tivation of osmY, whereas c70-dependent osmoregu-
lation through proU was strongly impaired [59].
The e¡ect of the cationic antibacterials on the
osmY expression implies that these peptides trigger
the cS-dependent stress response, that is the treated
cells go into stasis similar to that of late growth phase.
This possibility is consistent with the fact that E. coli
treated with the peptide antibacterials retain their
proton gradient without cell lysis for more than
20 min [15]. A functional relationship between the
OsmY protein in the periplasm and PxB is also sug-
gested by the plasmolytic response seen during the
¢rst few seconds after hyperosmotic shock [60]. This
is consistent with our hypothesis that both PxB and
OsmY protein form contacts between the phospho-
lipid interface surrounding the periplasmic space.
4.3. Signi¢cance of the lipid target and antibiotic
resistance
Our studies [15,16] have uncovered a novel anti-
bacterial mechanism based on a novel biophysical
phenomenon, that is, the peptide-mediated inter-
membrane exchange of phospholipids [38^40]. It is
intriguing that commonly used food preservatives,
hyperosmolar NaCl and sucrose, exhibit the same
pro¢le of the transcriptional responses, i.e., the
osmY and micF transcription is induced near the
minimum inhibitory concentration for the growth
by the antimicrobials. Also, the stasis is turned on
by the peptides in the early growth phase [60]. As a
fundamental process in bacterial physiology, control
of stasis through physical and metabolic circuits is
intrinsic in the functions of the osmY and micF gene
products. By way of evaluating the broad signi¢-
cance of the ¢nding we focus on the suggestion
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that a lipid-based antibacterial mechanism may not
succumb to resistance. However, as discussed below,
the dialectic is polarized by numerous alternatives.
For its action, the antimicrobial must enter the peri-
plasmic space, presumably by modifying the lipo-
polysaccharide layer. Since PxB interacts with the
Lipid A portion of LPS, modi¢cation of this site
may have a signi¢cant e¡ect on the entry step. This
is not inconsistent with the phospholipid target that
does not succumb to point mutation. Resistance or a
lack of susceptibility of Gram-negative organisms to
PxB has been reported [60^69], including the adaptive
resistance [51^53] possibly triggered by divalent cati-
onic environment [70,71]. Lesion in the resistant
strains appear to be localized in the LPS layer and
associated with the expression of OprH gene. Modi¢-
cation of Lipid A of lipopolysaccharide has also been
noted. Our results suggest that such adaptive changes
cannot be induced in all strains, and are readily rever-
sible. To explore the therapeutic and food preserva-
tive potential of antibacterial peptides, it will be nec-
essary to ¢nd out whether the ability to modify LPS is
present in all Gram-negatives, or if there are other
mechanisms to breach the outer membrane.
To recapitulate, the evolutionary success of cati-
onic peptide antimicrobials and their distribution in
wide-ranging organisms implies distinct advantage of
the underlying antimicrobial strategy. A better
understanding of the antimicrobial mechanism of
the peptides and hyperosmolar environment could
ultimately provide a strategy for a better control
and clinical management of infection in humans
and animals. Widespread selection and ubiquity of
antibacterial cationic peptides is possibly based on
a strategy that is integrated with the physiology of
stasis. Bacteria in stasis induced by the antimicro-
bials are likely to be cleared by the immune defense
system in the host. During stasis, bacteria are not
likely to loose their LPS, which minimizes the risk
of septic shock. Since the peptide antimicrobials do
not appear to enter the cytoplasm for their action,
they may not be susceptible to drug e¥ux resistance.
Similarly, inactivation of peptides by degradation
would also require a long-term evolutionary solution.
Obviously, some organisms do contain enzymes that
modify Lipid A, which prevents the binding of PxB.
Such an adoptive response must have a cost associ-
ated with it, because not all Gram-negatives seem to
posses the adaptive ability.
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